Monomeric pheophorbide(a)-containing poly(ethyleneglycol-b-ε- caprolactone) micelles for photodynamic therapy

51Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Incorporation of unaggregated monomeric molecules of pheophorbide(a) into micelles of poly(ethyleneoxide-b-ε-caprolactone) has been characterized by fluorescence spectroscopy, dynamic light scattering, transmission electron microscopy and asymmetric flow field flow fractionation. It was shown that the method used leads to 20 nm micelles, corresponding to approximately 200 molecules of polymer and 4 molecules of monomeric pheophorbide(a) per nano-object which was able to generate 1O2 in the medium. They have been used thereafter as nanocarriers for photosensitizers in photodynamic therapy against cancer cells. The encapsulation of photosensitizer has been verified and in vitro tests on human cancerous cells have revealed a ca. 2-fold enhanced photocytotoxicity and cellular uptake compared to free pheophorbide(a). © 2009 The Royal Society of Chemistry and Owner Societies.

Cite

CITATION STYLE

APA

Knop, K., Mingotaud, A. F., El-Akra, N., Violleau, F., & Souchard, J. P. (2009). Monomeric pheophorbide(a)-containing poly(ethyleneglycol-b-ε- caprolactone) micelles for photodynamic therapy. Photochemical and Photobiological Sciences, 8(3), 396–404. https://doi.org/10.1039/b811248g

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free